Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001425629 | SCV001628262 | likely benign | Gorlin syndrome; Medulloblastoma | 2023-03-31 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257864 | SCV002527212 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-06-27 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002257864 | SCV003863857 | likely benign | Hereditary cancer-predisposing syndrome | 2023-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |